A Chart Review to Evaluate the Safety and Efficacy of MeRT on Subjects With ASD

Completed

Conditions studied: Autistic Disorder

In brief

The purpose of this study is to evaluate the safety and efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) on subjects with Autism Spectrum Disorder (ASD).

Key facts

Study ID

NCT02758496

Run by

Wave Neuroscience

People needed

141

Starts

2016-04-01

Expected to finish

2017-04-01

Last updated by the study team

2017-05-09

Who can join

Age: 2 and older, up to 20. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Must have completed a baseline EEG at the Brain Treatment Center (BTC)
• Age between 2 and 20 years old at initial visit
• Must have a diagnosis of ASD according to the prevailing standard at that time (i.e., Diagnostic and Statistical Manual-IV (DSM-IV)) (ASD Group only)
• Must have received Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) for more than (5) sessions (ASD Group only)

You may not qualify if…

• Clinically significant abnormality or clinically significant unstable medical condition during treatment that in the Investigator's judgment may have may limited interpretation of the results.

Where it is running

• Brain Treatment Center — Newport Beach, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.